151 related articles for article (PubMed ID: 38533780)
1. Dalbavancin as long-term treatment in Corynebacterium striatum Infections: a literature review.
Camara-Rodriguez M; Jover-Diaz F; Delgado-Sánchez E; Infante-Urríos A; Peris-García J
Rev Esp Quimioter; 2024 Jun; 37(3):276-278. PubMed ID: 38533780
[No Abstract] [Full Text] [Related]
2. Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.
Hahn WO; Werth BJ; Butler-Wu SM; Rakita RM
Emerg Infect Dis; 2016 Nov; 22(11):1908-14. PubMed ID: 27767926
[TBL] [Abstract][Full Text] [Related]
3. Use of vancomycin for the treatment of Corynebacterium xerosis pneumonia.
Bayston R
Clin Infect Dis; 1995 Jul; 21(1):223. PubMed ID: 7578739
[No Abstract] [Full Text] [Related]
4. Sepsis due to multiply resistant Corynebacterium amycolatum.
de Miguel-Martinez I; Fernández-Fuertes F; Ramos-Macías A; Bosch-Benitez JM; Martín-Sánchez AM
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):617-8. PubMed ID: 8874085
[No Abstract] [Full Text] [Related]
5. Corynebacterium jeikeium osteomyelitis successfully treated with teicoplanin.
Munian MA; Martínez-Martínez L; Suarez AI; Corral JL; Lopez-Vizcaya F; Rodriguez-Baño J
J Infect; 1997 Nov; 35(3):325-6. PubMed ID: 9459422
[No Abstract] [Full Text] [Related]
6. Bacteremia due to high-level daptomycin-resistant Corynebacterium striatum: A case report with genetic investigation.
Hagiya H; Kimura K; Okuno H; Hamaguchi S; Morii D; Yoshida H; Mitsui T; Nishi I; Tomono K
J Infect Chemother; 2019 Nov; 25(11):906-908. PubMed ID: 31101531
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility pattern of Corynebacterium striatum.
Martínez-Martínez L; Pascual A; Bernard K; Suárez AI
Antimicrob Agents Chemother; 1996 Nov; 40(11):2671-2. PubMed ID: 8913489
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
Chudnicka A; Kozioł-Montewka M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020
[TBL] [Abstract][Full Text] [Related]
9. Teicoplanin treatment of Corynebacterium JK infection and colonization in an immunocompromised patient before and after marrow transplantation.
Manso E; Strusi P; Montillo M; Leoni P; Varaldo PE
J Chemother; 1989 Jul; 1(4 Suppl):714-5. PubMed ID: 16312604
[No Abstract] [Full Text] [Related]
10. Infections caused by antibiotic-resistant Corynebacterium group D2.
Soriano F; Fernández-Roblas R
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):337-41. PubMed ID: 3137032
[TBL] [Abstract][Full Text] [Related]
11. Male genitourinary infections by Corynebacterium glucuronolyticum. A review and clinical experience.
Ruiz-Pino M; Foronda-García-Hidalgo C; Alarcón-Blanco P; Gutiérrez-Fernández J
Rev Esp Quimioter; 2019 Oct; 32(5):479-484. PubMed ID: 31515978
[No Abstract] [Full Text] [Related]
12. Corynebacterium pseudogenitalium urinary tract infection.
Vedel G; Toussaint G; Riegel P; Fouilladieu JL; Billöet A; Poyart C
Emerg Infect Dis; 2006 Feb; 12(2):355-6. PubMed ID: 17080582
[No Abstract] [Full Text] [Related]
13. Multidrug-resistant Corynebacterium striatum endocarditis successfully treated with daptomycin.
Fernández Guerrero ML; Molins A; Rey M; Romero J; Gadea I
Int J Antimicrob Agents; 2012 Oct; 40(4):373-4. PubMed ID: 22817918
[No Abstract] [Full Text] [Related]
14. When Good Bugs Go Bad: Epidemiology and Antimicrobial Resistance Profiles of Corynebacterium striatum, an Emerging Multidrug-Resistant, Opportunistic Pathogen.
McMullen AR; Anderson N; Wallace MA; Shupe A; Burnham CA
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848008
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of Corynebacterium urealyticum encrusted cystitis: a case report and literature review.
Pierciaccante A; Pompeo ME; Fabi F; Venditti M
Infez Med; 2007 Mar; 15(1):56-8. PubMed ID: 17515676
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive update of dalbavancin activity when tested against uncommonly isolated streptococci, Corynebacterium spp., Listeria monocytogenes, and Micrococcus spp. (1357 strains).
Jones RN; Stilwell MG
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):239-40. PubMed ID: 23414746
[TBL] [Abstract][Full Text] [Related]
17. Treat Me Well or Will Resist: Uptake of Mobile Genetic Elements Determine the Resistome of
Leyton B; Ramos JN; Baio PVP; Veras JFC; Souza C; Burkovski A; Mattos-Guaraldi AL; Vieira VV; Abanto Marin M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299116
[No Abstract] [Full Text] [Related]
18. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.
Fernández-Roblas R; Prieto S; Santamaría M; Ponte C; Soriano F
Antimicrob Agents Chemother; 1987 May; 31(5):821-2. PubMed ID: 3606082
[TBL] [Abstract][Full Text] [Related]
19. Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs.
Gatti M; Andreoni M; Pea F; Viale P
Drug Des Devel Ther; 2021; 15():3349-3378. PubMed ID: 34376971
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of High-Level Daptomycin Resistance in
Goldner NK; Bulow C; Cho K; Wallace M; Hsu FF; Patti GJ; Burnham CA; Schlesinger P; Dantas G
mSphere; 2018 Aug; 3(4):. PubMed ID: 30089649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
